1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow CSL689: new trials by email Literature Review of CSL689 trials Research Report on CSL689
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency Eptacog alfa (activated) or pdFVII, CSL689 - Congenital Coagulation Factor VII Deficiency | Phase 1 | Completed | CSL Behring | 9 | 2015-07-01 | 2017-04-26 |
CSL Behring (1)
Netherlands (1) · Norway (1)
Alex Veldman (1)
2014 (1)